EB
RPRX icon

Eastern Bank’s Royalty Pharma RPRX Stock Holding History

Eastern Bank’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39M Buy
694,925
+35,547
+5% +$1.85M 0.6% 48
2026
Q1 		$31.6M Buy
659,378
+24,256
+4% +$1.06M 0.54% 50
2025
Q4 		$24.5M Buy
635,122
+263,867
+71% +$10.1M 0.42% 56
2025
Q3 		$13.1M Buy
371,255
+345,968
+1,368% +$12.5M 0.23% 79
2025
Q2 		$911K Sell
25,287
-1,157
-4% -$38.3K 0.02% 196
2025
Q1 		$823K Sell
26,444
-28,871
-52% -$915K 0.02% 219
2024
Q4 		$1.41M Sell
55,315
-659
-1% -$17.5K 0.03% 187
2024
Q3 		$1.58M Sell
55,974
-514
-0.9% -$14.2K 0.03% 194
2024
Q2 		$1.49M Sell
56,488
-414
-0.7% -$11.5K 0.06% 123
2024
Q1 		$1.73M Sell
56,902
-8,765
-13% -$258K 0.07% 120
2023
Q4 		$1.84M Sell
65,667
-11,316
-15% -$311K 0.08% 118
2023
Q3 		$2.09M Sell
76,983
-243,177
-76% -$7.22M 0.1% 114
2023
Q2 		$9.84M Buy
320,160
+623
+0.2% +$21.1K 0.47% 72
2023
Q1 		$11.5M Buy
319,537
+86,238
+37% +$3.2M 0.58% 69
2022
Q4 		$9.22M Buy
+233,299
New +$9.74M 0.49% 66

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Eastern Bank's RPRX Position: Q2 2026 in Review

Eastern Bank increased its Royalty Pharma (RPRX) stake by 5.4% in Q2 2026, buying an estimated $1.85M and bringing the position to 694,925 shares worth $39M. The position accounts for 0.6% of the portfolio, ranked #48.

Eastern Bank first reported a position in RPRX in Q4 2022 and has held it in 15 quarters since. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Eastern Bank held 694,925 shares of Royalty Pharma worth $39M as of Q2 2026.
  • Eastern Bank bought 35,547 Royalty Pharma shares in Q2 2026, an estimated $1.85M.
  • Royalty Pharma made up 0.6% of Eastern Bank's portfolio in Q2 2026, its #48 holding.
  • Eastern Bank first reported a position in Royalty Pharma in Q4 2022 and has held it in 15 quarters since.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.